Wang PX - Search Results

1

C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling.

Wang PX, Li ZM, Cai SD, Li JY, He P, Huang Y, Feng GS, Luo HB, Chen SR, Liu PQ. Wang PX, et al. Acta Pharmacol Sin. 2017 Sep;38(9):1257-1268. doi: 10.1038/aps.2017.38. Epub 2017 Jun 26. Acta Pharmacol Sin. 2017. PMID: 28649129 Free PMC article.

2

PKCζ interacts with STAT3 and promotes its activation in cardiomyocyte hypertrophy.

Li J, Gao H, Huang J, Wang P, Huang Y, Luo W, Zhang X, Shen P, You J, Cai S, Li Z, Liu P. Li J, et al. J Pharmacol Sci. 2016 Sep;132(1):15-23. doi: 10.1016/j.jphs.2016.03.010. Epub 2016 Mar 29. J Pharmacol Sci. 2016. PMID: 27094369 Free article.

3

Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling.

Feng GS, Zhu CG, Li ZM, Wang PX, Huang Y, Liu M, He P, Lou LL, Chen SR, Liu PQ. Feng GS, et al. Among authors: wang px. Acta Pharmacol Sin. 2017 May;38(5):638-650. doi: 10.1038/aps.2016.159. Epub 2017 Feb 27. Acta Pharmacol Sin. 2017. PMID: 28239158 Free PMC article.

4

SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction.

He P, Li Z, Yue Z, Gao H, Feng G, Wang P, Huang Y, Luo W, Hong H, Liang L, Chen S, Liu P. He P, et al. Mol Cell Endocrinol. 2018 Jan 15;460:1-13. doi: 10.1016/j.mce.2017.04.027. Epub 2017 Jun 1. Mol Cell Endocrinol. 2018. PMID: 28579116

5

PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.

Wang L, Li Z, Tan Y, Li Q, Yang H, Wang P, Lu J, Liu P. Wang L, et al. Mol Cell Endocrinol. 2018 Oct 15;474:137-150. doi: 10.1016/j.mce.2018.02.020. Epub 2018 Mar 1. Mol Cell Endocrinol. 2018. PMID: 29501586

6

JMJD3 inhibition protects against isoproterenol-induced cardiac hypertrophy by suppressing β-MHC expression.

Guo Z, Lu J, Li J, Wang P, Li Z, Zhong Y, Guo K, Wang J, Ye J, Liu P. Guo Z, et al. Mol Cell Endocrinol. 2018 Dec 5;477:1-14. doi: 10.1016/j.mce.2018.05.009. Epub 2018 May 10. Mol Cell Endocrinol. 2018. PMID: 29753027

7

PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Li Q, Li ZM, Sun SY, Wang LP, Wang PX, Guo Z, Yang HW, Ye JT, Lu J, Liu PQ. Li Q, et al. Among authors: wang lp, wang px. Acta Pharmacol Sin. 2019 May;40(5):589-598. doi: 10.1038/s41401-018-0044-4. Epub 2018 Jul 20. Acta Pharmacol Sin. 2019. PMID: 30030529 Free PMC article.

8

Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway.

Fang X, Liu Y, Lu J, Hong H, Yuan J, Zhang Y, Wang P, Liu P, Ye J. Fang X, et al. Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec;391(12):1373-1385. doi: 10.1007/s00210-018-1556-7. Epub 2018 Aug 21. Naunyn Schmiedebergs Arch Pharmacol. 2018. PMID: 30132020

9

sFRP1 has a biphasic effect on doxorubicin-induced cardiotoxicity in a cellular location-dependent manner in NRCMs and Rats.

Hu Y, Guo Z, Lu J, Wang P, Sun S, Zhang Y, Li J, Zheng Q, Guo K, Wang J, Jiang J, Liu P. Hu Y, et al. Arch Toxicol. 2019 Feb;93(2):533-546. doi: 10.1007/s00204-018-2342-5. Epub 2018 Oct 30. Arch Toxicol. 2019. PMID: 30377735

10

Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Li J, Huang J, Lu J, Guo Z, Li Z, Gao H, Wang P, Luo W, Cai S, Hu Y, Guo K, Wang L, Li Z, Wang M, Zhang X, Liu P. Li J, et al. Br J Pharmacol. 2019 Feb;176(3):416-435. doi: 10.1111/bph.14538. Epub 2018 Dec 9. Br J Pharmacol. 2019. PMID: 30414383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters